ROSHNI PATEL: Open Payments
NPI 1629320023 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$436 in 19 payments from 9 companies in 2025. Trend: 2023 $352 · 2024 $377 · 2025 $436
Food & beverage: $436
| Company | Payments | Amount |
|---|---|---|
| Melinta Therapeutics, LLC | 4 | $83 |
| ViiV Healthcare Company | 3 | $80 |
| Gilead Sciences, Inc. | 1 | $59 |
| Paratek Pharmaceuticals, Inc. | 3 | $52 |
| Insmed, Inc. | 2 | $43 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| Ferring Pharmaceuticals Inc. | 2 | $33 |
| Astellas Pharma US Inc | 1 | $28 |
| ABBVIE INC. | 1 | $21 |
Products named: Rezzayo, Epclusa, CABENUVA, NUZYRA, Arikayce, PREVYMIS, REBYOTA, Cresemba.
Industry payments across SC — which companies pay providers there.
